Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: June 15, 2016

Drugs and Therapeutics (D & T) Committee Meeting Results June 15, 2016
Drug Name	Review Type	Committee Recommendation	Prior Approval Status – Final Determination
Dyanavel XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Viberzi	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Savaysa	New Drug Appeal	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Orenitram	New Drug Appeal	Remove from Agenda	Removed from Agenda
Xeljanz	New Drug Appeal	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Xeljanz XR	New Drug Appeal	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Brilinta	PDL Appeal	Require Prior Approval	Prior Approval Required

Drugs and Therapeutics (D & T) Committee